Cargando…

Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval

(1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Linus, Lothian, Carina, Ådén, Ulrika, Lagercrantz, Hugo, Robertson, Nicola J., Setterwall, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658730/
https://www.ncbi.nlm.nih.gov/pubmed/34885261
http://dx.doi.org/10.3390/ma14237106
_version_ 1784612799492653056
author Olson, Linus
Lothian, Carina
Ådén, Ulrika
Lagercrantz, Hugo
Robertson, Nicola J.
Setterwall, Fredrik
author_facet Olson, Linus
Lothian, Carina
Ådén, Ulrika
Lagercrantz, Hugo
Robertson, Nicola J.
Setterwall, Fredrik
author_sort Olson, Linus
collection PubMed
description (1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emerging therapy for reducing death and severe disabilities in asphyxiated infants. Currently, this hypothermia is accomplished with equipment that needs a power source and a liquid supply. Neonatal cooling is more frequent in low-resource settings, where ~1 million deaths are caused by birth-asphyxia. (2) Methods: A simple and safe cooling method suitable for medical application is needed for the 28 to 37.5 °C window. (3) Results: Using empirical experiments in which the ingredients in Glauber salt were changed, we studied the effects of temperature on material in the indicated temperature range. The examination, in a controlled manner, of different mixtures of NaCl, Na(2)SO(4) and water resulted in a better understanding of how the different mixtures act and how to compose salt solutions that can satisfy clinical cooling specifications. (4) Conclusions: Our Glauber salt solution is a clinically suited PCM in the temperature interval needed for the cooling of infants suffering from asphyxia.
format Online
Article
Text
id pubmed-8658730
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86587302021-12-10 Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval Olson, Linus Lothian, Carina Ådén, Ulrika Lagercrantz, Hugo Robertson, Nicola J. Setterwall, Fredrik Materials (Basel) Article (1) Background: The field of medicine requires simple cooling materials. However, there is little knowledge documented about phase change materials (PCM) covering the range of 28 to 40 degrees Celsius, as needed for medical use. Induced mild hypothermia, started within 6 h after birth, is an emerging therapy for reducing death and severe disabilities in asphyxiated infants. Currently, this hypothermia is accomplished with equipment that needs a power source and a liquid supply. Neonatal cooling is more frequent in low-resource settings, where ~1 million deaths are caused by birth-asphyxia. (2) Methods: A simple and safe cooling method suitable for medical application is needed for the 28 to 37.5 °C window. (3) Results: Using empirical experiments in which the ingredients in Glauber salt were changed, we studied the effects of temperature on material in the indicated temperature range. The examination, in a controlled manner, of different mixtures of NaCl, Na(2)SO(4) and water resulted in a better understanding of how the different mixtures act and how to compose salt solutions that can satisfy clinical cooling specifications. (4) Conclusions: Our Glauber salt solution is a clinically suited PCM in the temperature interval needed for the cooling of infants suffering from asphyxia. MDPI 2021-11-23 /pmc/articles/PMC8658730/ /pubmed/34885261 http://dx.doi.org/10.3390/ma14237106 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Olson, Linus
Lothian, Carina
Ådén, Ulrika
Lagercrantz, Hugo
Robertson, Nicola J.
Setterwall, Fredrik
Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title_full Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title_fullStr Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title_full_unstemmed Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title_short Phase-Changing Glauber Salt Solution for Medical Applications in the 28–32 °C Interval
title_sort phase-changing glauber salt solution for medical applications in the 28–32 °c interval
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658730/
https://www.ncbi.nlm.nih.gov/pubmed/34885261
http://dx.doi.org/10.3390/ma14237106
work_keys_str_mv AT olsonlinus phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval
AT lothiancarina phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval
AT adenulrika phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval
AT lagercrantzhugo phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval
AT robertsonnicolaj phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval
AT setterwallfredrik phasechangingglaubersaltsolutionformedicalapplicationsinthe2832cinterval